STERIALS

A public benefit corporation (PBC)-based biopharmaceutical company that develops, manufactures, and sells drugs to treat pulmonary arterial hypertension, neuroblastoma, and other conditions. The company is actively pursuing a pipeline of R&D projects, including new indications, formulations, and delivery devices for existing products, and is also working to develop technologies to expand the availability of transplantable organs. The company is based in Delaware.